Literature DB >> 16378210

Nonsurgical treatment of patent arterial duct in term neonates with congenital heart disease: the role of intravenous indomethacin.

K Vandekerckhove1, D Macrae, Z Slavik.   

Abstract

We present two term neonates in which intravenous indomethacin usage was associated with successful closure of a persistently patent arterial duct. Both children had congenital heart disease with high pulmonary blood flow following surgical placement of contralateral systemic-pulmonary artery shunts.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16378210     DOI： 10.1007/s00246-004-0886-z

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  8 in total

1.  Intravenous indomethacin therapy in infants with a patent ductus arteriosus complicating other congenital heart defects.

Authors:  Ken Watanabe; Hideshi Tomita; Yasuo Ono; Osamu Yamada; Ken-ichi Kurosaki; Shigeyuki Echigo
Journal:  Circ J       Date:  2003-09       Impact factor: 2.993

2.  Absent pulmonary valve syndrome with intact ventricular septum: role of ductus arteriosus revisited.

Authors:  J Podzimkova; M S Hickey; Z Slavik; R Leanage; K C Chan
Journal:  Int J Cardiol       Date:  1997-09-19       Impact factor: 4.164

3.  Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial.

Authors:  Paola Lago; Tiziana Bettiol; Sabrina Salvadori; Isabella Pitassi; Andrea Vianello; Lino Chiandetti; Onofrio S Saia
Journal:  Eur J Pediatr       Date:  2002-04       Impact factor: 3.183

Review 4.  Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis.

Authors:  P W Fowlie; P G Davis
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

5.  Decreased contractility of the ductus arteriosus in experimental pulmonic stenosis.

Authors:  L Mahony; R I Clyman; M A Heymann
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

6.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

Review 7.  Pharmacologic management of patent ductus arteriosus.

Authors:  V Bhatt; M C Nahata
Journal:  Clin Pharm       Date:  1989-01

8.  The ductus arteriosus and stenoses of the pulmonary arteries in pulmonary atresia.

Authors:  N J Elzenga; A C Gittenberger-de Groot
Journal:  Int J Cardiol       Date:  1986-05       Impact factor: 4.164
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.